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Abstract
Clinical, pathological and genetic examination revealed an as yet uncharacterized juvenile-
onset neuroaxonal dystrophy (NAD) in Spanish water dogs. Affected dogs presented with
various neurological deficits including gait abnormalities and behavioral deficits. Histopa-
thology demonstrated spheroid formation accentuated in the grey matter of the cerebral
hemispheres, the cerebellum, the brain stem and in the sensory pathways of the spinal
cord. Iron accumulation was absent. Ultrastructurally spheroids contained predominantly
closely packed vesicles with a double-layered membrane, which were characterized as
autophagosomes using immunohistochemistry. The family history of the four affected dogs
suggested an autosomal recessive inheritance. SNP genotyping showed a single genomic
region of extended homozygosity of 4.5 Mb in the four cases on CFA 8. Linkage analysis
revealed a maximal parametric LOD score of 2.5 at this region. By whole genome re-
sequencing of one affected dog, a perfectly associated, single, non-synonymous coding
variant in the canine tectonin beta-propeller repeat-containing protein 2 (TECPR2) gene
affecting a highly conserved region was detected (c.4009C>T or p.R1337W). This canine
NAD form displays etiologic parallels to an inherited TECPR2 associated type of human
hereditary spastic paraparesis (HSP). In contrast to the canine NAD, the spinal cord lesions
in most types of human HSP involve the sensory and the motor pathways. Furthermore, the
canine NAD form reveals similarities to cases of human NAD defined by widespread spher-
oid formation without iron accumulation in the basal ganglia. Thus TECPR2 should also be
considered as candidate gene for human NAD. Immunohistochemistry and the ultrastruc-
tural findings further support the assumption, that TECPR2 regulates autophagosome
accumulation in the autophagic pathways. Consequently, this report provides the first
genetic characterization of juvenile canine NAD, describes the histopathological features
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associated with the TECPR2mutation and provides evidence to emphasize the association
between failure of autophagy and neurodegeneration.
Introduction
Neuroaxonal dystrophies (NAD) in humans and animals represent a group of rare, heteroge-
neous inherited neurodegenerative conditions with clinical and pathological overlapping
manifestations [1], [2]. Although they all share the characteristic pathologic feature, i.e. the
development of spheroids, there is variation in the clinical and the neurological signs, the pro-
gression of the disease and lesion distribution between, but also within species. Besides present-
ing as a primary central nervous system (CNS) disorder, NAD-like findings may occur
associated with aging and secondary to several metabolic-toxic conditions [3]. The nomencla-
ture of primary human NADs is complex due to the classification of the subtypes according to
i) historical terminations, ii) underlying genetic mutations, iii) the presence or absence of iron
accumulations in the basal ganglia, or iv) the age of onset and clinical symptoms (S1 Table).
The prevalent genetic associations for human NAD comprise the autosomal recessive inherited
mutations in pantothenate kinase 2 (PANK2; OMIM 606157), phospholipase A2, group VI
(PLA2G6; OMIM 603604), and chromosome 19 open reading frame 12 (C19orf12; OMIM
614297), whereas other types of NAD are less frequent [4], [5], [6], [7]. Recently, one X-linked
variant associated with a mutation in the autophagy related WD repeat domain 45 (WDR45;
OMIM 300526) gene was reported, representing the first direct link between the autophagy
machinery and neurodegeneration [8]. However, numerous idiopathic types of late infantile,
juvenile, and adult NAD are genetically not classified [9]. The histological hallmark of NAD is
defined by localized axonal swellings (spheroids) with distal axonal atrophy and secondary
myelin degradation [9], [10]. Spheroids containing protein aggregations, membranous vesicu-
lar structures, mitochondria, and/or neurofilaments are also found in amyotrophic lateral scle-
rosis, Huntington’s disease, Alzheimer’s and familial Parkinson’s disease as well as human
hereditary spastic paraparesis (HSP) [11], [12], [13], [14], [15], [16]. In all these neurodegener-
ative conditions, impairment of autophagy is discussed as a crucial pathomechanism [17].
Autophagy, which is part of the normal cell homeostasis, is involved in the basal constitutive
turnover of cytosolic components and is activated by stress signals such as nutrient starvation
and oxidative stress. The first step in this process implies the sequestration of damaged organ-
elles, long-lived proteins, and protein aggregations into double-membrane vesicles called
autophagosomes. Fusion of autophagosome and lysosome provides further degradation and
subsequent release of amino acids and other molecules into the cytoplasm [18]. Autophagy is
especially important for the metabolic homeostasis of neurons as post-mitotic cells with a high
energy demand [17]. Due to genetic associations and corresponding experimental studies, the
relevance of this pathway and its implication as a therapeutic target in the treatment of neuro-
degenerative diseases is a current topic in neuroscience.
Canine NAD has previously been reported in Collie sheep dogs, Rottweiler dogs, Jack Russel
Terriers and Papillon dogs. However, only one form of canine NAD with fetal onset in labora-
tory dogs (Schnauzer-Beagle crossbreed) has been characterized at the molecular level [2],
[19]. The affected gene encodes mitofusin 2 (MFN2; OMIA 000715–9615), a protein mediating
mitochondrial fusion but also clearance of damaged mitochondria via selective autophagy [19].
The present study reports positional cloning of a TECPR2missense mutation causing NAD in
Spanish water dogs, with evidence of disturbances of the neuronal autophagy pathway.
TECPR2 Associated Canine NAD
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Results
Clinical and histopathological characterization of NAD in the Spanish
water dog
Four Spanish water dogs presented with slowly progressing neurological signs starting between
six and eleven months of age. Owners reported gait abnormalities, behavioral changes (dull-
ness, nervousness, vocalization) and incontinence alone or in combination with uncontrolled
defecation. All dogs showed a mild head tilt, generalized mild cerebellar ataxia with hyperme-
tria of the thoracic limbs and absent to depressed patellar reflexed. Additionally, affected dogs
displayed varying degrees of compulsory pacing, proprioceptive deficits, decreased menace,
visual deficits, positional nystagmus and decreased muscle tone (S1 Video). Based on the neu-
rological examination the disorder is characterized by a multifocal, predominantly sensory,
localization. Complete blood count and chemistry profile were within reference ranges. Analy-
sis of the cerebrospinal fluid showed normal cell counts and protein values. All affected dogs
were euthanized at the owners request between 12 and 23 months of age.
In all affected dogs pathomorphological findings were restricted to the CNS. In the brain,
neuronal loss and spheroid formation of variable degree was present, accentuated within the
grey matter including the cerebral hemispheres, the cerebellum, and the brain stem. The lesions
were most prominent and consistently found in the dorsolateral nuclei of the brain stem,
including the cuneate and vestibular nuclei and the nucleus of the spinal tract of the trigeminal
nerve. Sporadic spheroids were also present in the white matter of the brain. In the spinal cord
neuronal loss and/or spheroid formation was restricted to the sensory pathways including the
dorsal horn as well as the gracile and the cuneate fasciculi. In the spinal cord of diseased ani-
mals the number of spheroids ranged between 38 and 103 spheroids per mm2 in the gray mat-
ter and between 1 to 1.5 spheroids per mm2 in the white matter. No spheroids were found in
the spinal cord of four age matched control beagle dogs. The spheroids in diseased Spanish
water dogs represented demarcated nodular swellings with accumulations of a finely granular
eosinophilic material. Several spheroids displayed a central hypereosinophilic target-like core
structure (Fig 1A). Similar structural alterations were additionally detected in few neurons
associated with the soma (Fig 1B). Using Turnbull’s blue and Prussian blue staining, no iron
deposition was observed within the CNS (S1 Fig). No spheroid formation was diagnosed in the
peripheral nerves.
Fig 1. Histology of NAD in Spanish water dogs. (A, B) Histology of the brain stem (cuneate nucleus) stained with hematoxylin and eosin revealed
numerous large granular axonal swellings (spheroids; arrow). Note the hypereosinophilic central target-like core structure of distinct spheroids (A). Single
neurons displayed an accumulation of a finely or coarse granular, intensely eosinophilic material associated with the soma (arrow) displacing the Nissl
substance. A high proportion of neurons adjacent to affected areas displayed a normal morphology with equally distributed Nissl substance (arrowhead, B).
doi:10.1371/journal.pone.0141824.g001
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NAD in Spanish water dogs maps to a 4.5 Mb region on CFA 8
To characterize a possible gene defect, blood samples from the four diseased dogs and 15
related dogs were collected (Fig 2). Both, female and male offspring were affected. Parents of
affected dogs showed no clinical signs of the disease. The four affected dogs could be traced
back to common ancestors (Fig 2). The pedigree therefore indicated a monogenic autosomal
recessive inheritance of NAD. Under this scenario the NAD affected dogs were considered to
be identical by descent (IBD) for the causative mutation and flanking chromosomal segments.
A homozygosity mapping approach was therefore applied to determine the position of the
mutation in the canine genome. More than 170 000 evenly spaced SNPs of the four affected
and 13 phenotypically healthy Spanish water dogs were genotyped. The four cases were ana-
lyzed for extended regions of homozygosity with simultaneous allele sharing. A total of four
genomic regions were identified being IBD in the genotyped cases. Only on CFA 8, in a region
containing 288 SNP markers corresponding to a 4.47 Mb interval from 67.54 to 72.01 Mb all
diseased dogs were homozygous in contrast to the 13 phenotypical healthy controls. The other
three regions of shared homozygosity among the four cases were located on CFA 13, 25, and 32
and contained only 69, 55, and 3 SNPs corresponding to 0.88, 0.71, and 0.03 kb, respectively.
For linkage analysis, the pedigree was split into two sub-pedigrees because of inbreeding loops
and missing DNA samples. The estimated maximal parametric LOD score of 2.5 at 70 Mb on
CFA 8 suggested linkage of NAD to the candidate region identified before (S2 Fig).
Fig 2. Pedigree of the collected Spanish water dogs with NAD.Note the inbreeding loops and the likely common ancestors appearing 8 to 9 generations
ago. Only for the numbered animals DNA was available. Affected animals are shown with black symbols; genotyped carriers of the causative mutation are
indicated with half-filled symbols; females are shown as circles and males as squares.
doi:10.1371/journal.pone.0141824.g002
TECPR2 Associated Canine NAD
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A TECPR2missense mutation is associated with NAD in Spanish water
dogs
A total of 58 genes and loci are annotated in the critical interval on CFA 8. To obtain a compre-
hensive overview of all variants in the critical interval the whole genome of one NAD affected
Spanish water dog was sequenced. The recessive inheritance and the fatal effect of the mutation
suggested a loss of function mutation affecting splicing, expression or the coding sequence of
the gene responsible for this type of NAD. Therefore, special emphasis was paid to variants
located within the exons or within the splice sites of the annotated genes in the targeted region
of the canine genome. SNP and indel variants were characterized with respect to the reference
genome of a presumably non-affected Boxer (CanFam 3.1). Additionally, the genotypes of the
affected dog were aligned with 119 dog genomes of various breeds that had been sequenced in
the course of other ongoing studies. The pedigree analysis and the large size of the IBD segment
indicated a relatively young origin of the mutation. Thus it was hypothesized that the mutant
allele of the causative variant should be completely absent in all other dog breeds except the
Spanish water dogs. It was considered unlikely that the mutant allele would have been intro-
gressed into any other breeds outside the Spanish water dog. Within the critical interval on
CFA 8, 63 private variants were noticed, of which only a single one was predicted to affect the
coding sequence of an annotated gene. Only the affected dog had the homozygous variant
genotype and all other 119 sequenced dogs carried the homozygous wildtype genotype. This
remaining private non-synonymous variant in the tectonin beta-propeller repeat-containing
protein 2 gene (TECPR2 c.4009C>T) was genotyped in larger cohorts of dogs including the
family members, unrelated controls of Spanish water dogs, and dogs of related breeds like
other Iberian dog breeds (Table 1). The TECPR2 variant remained perfectly associated with
the NAD phenotype in more than 300 Spanish water dogs. Within the family material, only
affected dogs were homozygous TT and available parents and grandparents were heterozygous
CT. The variant was absent from a selection of dogs from other breeds.
The TECPR2 mutation affects a highly conserved domain
The NAD associated mutation in Spanish water dogs is located within the tectonin beta propel-
ler repeat domaine 6 of the TECPR2 protein (Fig 3A and 3B) resulting on protein level in an
Table 1. Association of the TECPR2missensemutation with the NAD phenotype in Spanish water
dogs.
TECPR2 (c.4009C>T)
CC CT TT
Spanish water dog (Perro de Agua Español)
Cases 4
Relatives 3 12
Controls 261 21
Related dog breeds
Barbet 20
Briard 5
Cão da Serra de Aires 15
Portugese Waterdog (Cão de Água Português) 3
Lagotto Romagnolo 67
Standard Poodle 13
Other breeds 146
Total 533 33 4
doi:10.1371/journal.pone.0141824.t001
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exchange of the basic amino acid arginine against the nonpolar, aromatic tryptophan (p.
R1337W). Multiple species protein alignment showed that the wildtype residue at the affected
position is conserved across all known TECPR2 orthologs in vertebrates including the zebrafish
(Danio rerio; Fig 3B). Alignment with the related TECPR1 paralogs revealed that the affected
protein motif is highly conserved including in nematodes and the fruit fly paralog (S3 Fig).
Software based analysis of the NAD associated TECPR2 amino acid exchange characterized
the mutation as destabilizing (PoPMuSiC) and highly damaging (PolyPhen 2), whereas no
effect on the secondary structure and disorder were predicted (NetTurnP, NetSurfP, CFSSP,
Phyre 2).
The TECPR2 mutation results in autophagosome accumulation within
axons
Transmission electron microscopy of the spheroids revealed intraaxonal accumulations of
closely packed vacuoles rimmed by two parallel membrane layers separated by an electron-
lucent cleft, consistent with the morphology of autophagosomes (Fig 4A), [20]. Furthermore, a
loss of the myelin sheets around the axonal dilatations was present. In the axons of a control
animal, only single vacuolar structures, interpreted as mitochondria are found (Fig 4B).
Immunohistochemistry using antibodies against the autophagosomal protein microtubule-
associated protein 1A/1B-light chain 3 B (LC3B), the lysosome-associated membrane protein 2
(LAMP2), and the late endosome marker RAB7 confirmed an accumulation of autophago-
somes within spheroids (Fig 5A), whereas only few lysosomes (Fig 5B) and late endosomes
(Fig 5C) are present. Using an antibody directed against human TECPR2, no TECPR2 expres-
sion was found within spheroids (Fig 5D), whereas neurons and glial cells stained positive in
affected and control animals (S4 Fig). This suggests that the TECPR2 mutation does not affect
TECPR2 expression, but implicates impaired TECPR2 function. However, the specificity of the
TECPR2 antibody used was not tested by western blot.
Discussion
The positional cloning study identified a missense mutation in TECPR2 as the very likely cause
for a previously uncharacterized juvenile-onset form of canine NAD in Spanish water dogs.
The affected TECPR2 protein is involved in autophagy, but its detailed function in this path-
way is largely unknown [21], [22]. A recent study described a TECPR2mutation causing hered-
itary spastic paraparesis (HSP) in humans, designated as SPG49 (OMIM 615031), [21].
Human patients affected by the TECPR2mutation presented with hypotonia during their sec-
ond year of life and some individuals developed a progressive spasticity until the end of the
first decade of life [21]. Histopathology of the human SPG49 patients was only performed from
muscle biopsies that were unremarkable similar to the absence of lesions in the muscles from
NAD affected dogs [21]. Clinically affected diseased dogs displayed ataxia and paresis charac-
terized by loss of muscle tone and decreased to absent patellar reflexes with no signs of spastic-
ity or muscle atrophy. The distribution of the pathologic lesions was widespread in the CNS
and involvement of the afferent pathways in the spinal cord was consistent with the clinical pic-
ture indicating predominantly sensory deficits (Fig 6). However, all affected dogs in this study
were euthanized and the natural progression of NAD in the Spanish water dog needs to be fur-
ther studied and characterized. The neuropathology of SPG 49 patients is not yet described.
However, in the spinal cord of different murine HSP and various types of human HSP autopsy
cases, lesions were consistently found in the gracile fasciculus of the cervical spinal cord, but
also in the corticospinal tract and descending motor pathways of the thoracic segment [16].
The loss of motor signal transmission from the brain to the body periphery via the descending
TECPR2 Associated Canine NAD
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motor pathways and the spinal cord ventral horn neurons results in loss of motor functions,
respectively, as muscle weakness and/or spasticity due to increased spinal reflexes (Fig 6) [16].
Fig 3. TECPR2 domain structure and p.R1337Wmutation associated with NAD in Spanish water dogs. (A) TECPR2 possesses three N-terminal WD
(tryptophan-aspartic-acid dipeptide) repeats (red), a polylysine tract (green), and six C-terminal tectonin beta-propeller repeat (TECPR) domains (blue). (B)
The arginine at position 1337 that is substituted by a tryptophan residue (red) is located in the sixth TECPR domain. Note that the mutation affects a
conserved amino acid residue in all known TECPR2 orthologs. Highly conserved residues are marked in green.
doi:10.1371/journal.pone.0141824.g003
TECPR2 Associated Canine NAD
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Interestingly, similar clinical findings and spinal cord lesions corresponding to NAD in the
Spanish water dog have been described in humans. One human report describes tetraparesis,
hyporeflexia and visual disturbances with disease onset at 18 months of age. [23]. Histopathol-
ogy revealed absence of iron accumulations, spheroid formation accentuated in the brain stem
and spinal cord, restricted to the dorsal horns, whereas peripheral nerves were unaffected [23].
This case was described as an atypical form of NAD, but the genetic association is unknown.
Consequently, TECPR2 might represent a potential candidate gene for late infantile or juvenile
cases of NAD in humans that are not associated with a mutation in PLA2G6 and are character-
ized by the lack of iron accumulations, absence or progressive development of spasticity, visual
disturbances and absence of peripheral nerve lesions. In this regard, it has to be considered that
PLA2G6 associated NAD involves the dorsal and ventral horns of the spinal cord as well
as peripheral nerves, as demonstrated in humans and murine PLA2G6models (http://www.
informatics.jax.org/disease/256600), [24], [25], [26].
Except of cases with underlying PLA2G6mutations the accumulation of iron in defined
brain regions is frequently present in human NAD [27]. Iron deposition was not reported in
SPG49 patients comparable to NAD affected Spanish water dogs [21]. In humans, it is sug-
gested that iron deposition may be lacking in the early phase of neurodegeneration with brain
iron accumulation (NBIA) [1], [28]. Since the NAD affected Spanish water dogs were eutha-
nized aged between 1 and 2 years, iron depositions at later stages of the disease cannot be
excluded. Recently, a novel NBIA type associated with a mutation inWDR45 was reported and
defined as “beta-propeller protein-associated neurodegeneration” (BPAN) [8], [29]. The
WDR45 protein possesses such as TECPR2 an N-terminal WD domain and is suggested to reg-
ulate autophagosome accumulation [30]. Necropsy of a BPAN patient revealed large numbers
of spheroids and prominent iron deposits [29]. The presence of spheroids implicating axonal
degeneration and the absence of iron deposits in NAD affected Spanish water dogs and also
Atg7 knock-out mice suggests that the iron deposits represent a secondary event in autophagy
related neurodegeneration [31].
Fig 4. Transmission electronmicroscopy of spinal cord spheroids compared to a normally structured axon. Ultrastructurally, spheroids lacked
myelin sheaths and contained closely packed accumulations of membrane-bound vacuolar structures. High numbers of vacuoles were rimmed by a double
layered membrane separated by an electron-lucent cleft and defined as autophagosomes (insert; A). The axons of a healthy, age matched Beagle dog is
surrounded by a thick myelin sheath (arrowhead). Isolated vacuolar structures, interpreted as mitochondria (arrow) are present between neurofilaments (B).
(A) Bar: overview: 1 μm; insert 0.5 μm. (B) Bar: 2.3 μm.
doi:10.1371/journal.pone.0141824.g004
TECPR2 Associated Canine NAD
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Fig 5. Expression of autophagosome, lysosome and late endosome associated proteins in the spinal
cord white matter of an NAD affected Spanish water dog (A-D) and an age matched control Beagle
dog (E-H). (A) In the affected Spanish water dog, immunohistochemistry using a LC3B specific antibody
demonstrated an autophagosome accumulation within spheroids. Only few LAMP2 positive lysosomes (B)
and RAB7 stained late endosomes (C) are present within spheroids. No TECPR2 accumulations are found
within spheroids (D). In diseased Spanish water dogs, LC3B, LAMP2 and TECPR2 are strongly expressed in
glial cells and axons without spheroid formation. In the age matched healthy Beagle dog, LC3B (E), LAMP2
(F) and TECPR2 (H) positive staining is found in axons and glial cells. RAB 7 (G) positive staining is restricted
to glial cells. Bar: 20 μm. A-H: Nomarski differential interference-contrast optic.
doi:10.1371/journal.pone.0141824.g005
TECPR2 Associated Canine NAD
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On the molecular level, SPG49 was associated with a single base deletion within exon 16 of
TECPR2 that introduces a frame shift, results in a premature stop codon and leads to subse-
quent proteasomal degradation of the truncated protein [21]. In the diseased Spanish water
dogs, TECPR2 accumulations were not detected in spheroids using immunohistochemistry.
This finding suggests that the neuropathology, especially the axonal swellings and vacuolar
accumulations, was not the consequence of axonal TECPR2 aggregations, but result from defi-
cits in TECPR2 function. The functional relevance of the arginine residue mutated in canine
NAD is supported by its evolutionary high interspecies conservation, even in nematodes and
Fig 6. Distribution of cervical and thoracic spinal cord spheroids in Spanish water dogs with NAD compared to mostly affected areas in human
hereditary spastic paraparesis (HSP). In NAD affected Spanish water dogs (left), spheroids and neuronal loss were restricted to the sensory, ascending
pathways localized to the grey matter of the spinal cord dorsal horn and single large spheroids were detected within the cuneate and gracile fasciculus. This
might explain the clinical signs as gait disturbances, proprioceptive deficits, decreased spinal reflexes and urinary incontinence. In other human forms of
NAD, HSP and Pla2g6 knock-out mice (right), spinal cord spheroid formation is accentuated in the sensory pathways including the gracile fasciculus as well
as the corticospinal tracts. Furthermore, also the descending motor pathways including the ventral horns as well as the descending pyramidal tracts are
affected. Note that spinal cord histology of TECPR2 associated HSP in humans is unknown. Ascending, sensory pathways (red; transmission of sensory
signals from the periphery (red arrow) via dorsal horn (DH) towards the brain): Dorsal funiculus composing of gracile fasciculus (GF) and cuneate fasciculus
(CF); Spinocerebellar tracts with: dorsal spinocerebellar tract (DST) and ventral spinocerebellar tract (VST); Descending, motor pathways (blue; signal
transmission via the ventral horn (VH) neurons towards the muscles; blue arrow): Pyramidal tracts with lateral corticospinal tract (LCT) and ventral
corticospinal tract (VCT).
doi:10.1371/journal.pone.0141824.g006
TECPR2 Associated Canine NAD
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the fruit fly paralog TECPR1. Similar to TECPR1, TECPR2 was suggested to regulate autopha-
gosome maturation and accumulation [21], [22], [32]. Spheroids in NAD affected Spanish
water dogs contained high proportions of autophagosomes, whereas only few late endosomes
and lysosomes were found. This observation supports that TECPR2 regulates autophagosome
accumulation also in neurons. In general, this finding may result from increased autophago-
some production, disturbances of vesicle transport and/or impairments of autophagosome
fusion with late endosomes or lysosomes. TECPR1 was demonstrated to provide autophago-
some-lysosome fusion [32]. However, in neurons the fusion between autophagosomes and
lysosomes is suggested to occur in the soma [33]. Histology of NAD affected Spanish water
dogs identified primary axonal lesions, whereas only a few neuronal cell bodies were affected.
Consequently, disturbed autophagosome-lysosome fusion seems not the main pathomechan-
ism in TECPR2mutation associated autophagosome accumulation. Additionally, neuronal loss
and spheroid formation were restricted to specific brain and spinal cord localizations. This
finding indicates that specific neuronal subpopulations depend on TECPR2 function or autop-
hagy in general, whereas compensatory mechanisms may exist in other neurons.
NAD and HSP both represent neurodegenerative diseases with overlapping clinical and his-
topathological features. A distinct classification without knowledge of the underlying genetics
remains challenging [1]. After the identification ofWDR45mutations linking autophagy and
neurodegeneration, the association of other NAD or HSP related genes including SPG11
(OMIM 604360), SPG15 (OMIM 270700), and SPG60 (OMIM 612167) was demonstrated [8],
[34], [35], [36], [37]. Further NAD and HSP associated genes encode proteins involved in
mitochondrial and lipid metabolism, axonal transport, endoplasmatic reticulum (ER) mor-
phology, ER protein quality control, ER-associated protein degradation as well as endosome or
membrane trafficking and vesicle formation [7], [16]. Interestingly, all these pathways are
closely linked to autophagy [38], [39], [40], [41], [42]. Therefore, autophagy modulation has to
be anticipated for numerous other NAD, NBIA, and especially SPG associated genes. Thus,
HSP and NAD pathogenesis may primary involve disturbances of different subcellular com-
partments, which generally affect the autophagy pathway. Consequently, the analysis of the
functions of NAD, NBIA, and SPG associated proteins as well as their interactions might pro-
vide critical clues for a deeper understanding of neuronal autophagy and autophagy associated
neurodegeneration.
Summarized, a disease causing mutation in the canine TECPR2, a known human HSP asso-
ciated gene, was identified as the highly likely cause of NAD in Spanish water dogs. In addition,
TECPR2may represent a suitable candidate for canine and human NAD cases with unknown
genetic etiology. However, the identification of new NAD and HSP candidate genes enables an
early diagnosis but therapy is still restricted to symptomatic and palliative treatments. This
study shows that the identification of disease associated mutations in dogs adds valuable
insights into the understanding of specific pathomechanisms of similar diseases in humans.
Specifically canine axon length makes dogs a more suitable translational model for human
studies in comparison to mice. Therefore, NAD affected Spanish water dogs represent a valu-
able large animal model enabling not only detailed studies on TECPR2 function but also on the
relevance of autophagy in neuronal maintenance.
Materials and Methods
Ethics Statement
Affected Spanish water dogs were examined with the consent of their owners and under ethical
approval from the Uppsala Animal Experiment Ethics Board, Sweden. The tissue of the control
TECPR2 Associated Canine NAD
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Beagle dogs used for electron microscopy and immunohistochemistry derived from the archive
of the Department of Pathology, University of Veterinary Medicine Hannover, Germany.
Clinical characterization of NAD
Three affected dogs underwent a complete neurological examination according to standardized
protocols by a veterinary neurologist because of gait abnormalities, behavioral changes, and
incontinence with an insidious onset between six and eleven months of age. The fourth dog
was examined by another veterinarian; however a video-recording showing the dog’s gait was
available for evaluation. A complete blood count and serum chemistry profile were analyzed in
all affected dogs. A cerebrospinal fluid sample was collected from the cisterna magna in two of
the affected dogs. One dog was anesthetized with propofol intravenously for inspection of the
vocal folds. Due to the progression of clinical signs affected dogs were euthanized within a few
months to over a year after clinical signs became obvious to the owners.
Pathological examination
Complete necropsies were performed of three affected dogs. In the fourth case, only the brain
was available for examination. Pathological examination was performed according to standard-
ized procedures at the Department of Pathology, Pharmacology and Toxicology, Swedish Uni-
versity of Agricultural Sciences, Uppsala. Representative samples of all organs and tissues were
collected, fixed in 10% neutral buffered formalin, and routinely processed in paraffin wax.
Five μm thick tissue sections were stained with haematoxylin and eosin.
Electron microscopy
For transmission electron microscopy, sections of formalin fixed cervical spinal cord and brain
stem were fixed for 24 h in 2.5% glutaraldehyde solution, rinsed with 0.1% sodium cacodylate
buffer (pH 7.2), postfixed in 1% osmium tetroxide, and embedded in EPON 812 (SERVA Elec-
trophoresis GmbH, Heidelberg, Germany) as described [43]. Sections were stained with lead
citrate and uranyl acetate and investigated using an EM 10c (Carl Zeiss Jena GmbH, Oberko-
chen, Germany).
Immunohistochemistry
Immunohistochemistry was performed as described [44, 45] on formalin-fixed, paraffin-
embedded tissue sections using rabbit polyclonal antibodies against LAMP2 (ab18528, dilution
1: 100, Abcam, Cambridge, United Kingdome), LC3B (ab48394, dilution 1:800, Abcam), RAB7
(ab77993, dilution 1:50, Abcam) and the human TECPR2 specific antibody (HPA000658; dilu-
tion 1:50; Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany). PBS was used for antibody
dilution. To block endogenous peroxidase, tissue sections were treated with 0.5% H2O2 diluted
in 80% ethanol, heated in sodium citrate buffer, and incubated with 20% goat serum to block
non-specific binding sites. Subsequently, sections were incubated with the primary antibodies
overnight at 4°C. Control sections were incubated with normal rabbit serum (R4505; dilution:
1:3000, Sigma-Aldrich). Biotinylated goat-anti-rabbit IgG (BA-1000; dilution: 1:200; Vector
Laboratories, Burlingame, CA, USA) was used as secondary antibody. As detection system, the
avidin-biotin-peroxidase complex (ABC) method (Vector Laboratories) was applied using
3,30-diamino-benzidine tetrahydrochloride (DAB) as chromogen. Sections were slightly coun-
terstained with Mayer's hematoxylin and mounted.
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Animals
Blood samples from four NAD-affected Spanish water dogs, their healthy littermates (n = 9),
sires (n = 2), dams (n = 3), a single grand sire, as well as of 263 unrelated control dogs of this
breed were collected. Genomic DNA was isolated from blood using the Nucleon Bacc2 kit (GE
Healthcare, Glattbrugg, Switzerland) and the DNeasy blood and tissue kit (Qiagen, Hombrech-
tikon, Switzerland) according to manufacturer instructions. DNA samples of phenotypically
related dog breeds like Barbet (n = 20), Briard (n = 5), Cão da Serra de Aires (n = 15), Cão de
Água Português (Portuguese Waterdog) (n = 3), Lagotto Romagnolo (n = 67), Standard Poo-
dles (n = 12), as well as 146 control dogs of various other breeds were collected during the
course of other research projects at the Institute of Genetics, University of Bern, Switzerland.
Genetic mapping
Genomic DNA from four cases and thirteen related phenotypically healthy dogs was geno-
typed on the Illumina CanineHD BeadChip (Illumina, San Diego, USA) containing more than
170,000 evenly spaced and validated SNPs derived from the CanFam3.1 assembly. To identify
extended homozygous regions with allele sharing across cases and controls, the following
PLINK software commands were used:—maf 0,—max-maf 1.0,—geno 0.01,—hwe 0,—mind
0.15,—homozyg,—homozyg-match 1,—homozyg-group [46]. All given positions correspond
to the CanFam3.1 genome assembly. Multipoint parametric linkage analyses were performed
with MERLIN software version 1.1.2 [47]. For parametric linkage, LOD scores were calculated
under both, homogeneity and heterogeneity, under the assumption of NAD segregating as a
biallelic autosomal recessive trait, with complete penetrance. The frequency of the disease allele
in the considered population is unknown and there is no data available that would make it pos-
sible to estimate the frequency in a reliable manner. For the calculations a frequency of 0.01 for
the mutated allele was assumed.
Whole genome sequencing of one affected Spanish water dog
A standard fragment library was prepared with 300 bp insert size and one lane of illumina
HiSeq2000 paired-end reads (2×100 bp) was collected. 189 million 100 bp paired-end reads
were collected corresponding to roughly 10x coverage of the genome. The reads were mapped
to the dog reference genome using the Burrows-Wheeler Aligner (BWA) version 0.5.9-r16
with default settings [48]. PCR duplicates were labelled with Picard tools (http://sourceforge.
net/projects/picard/). Local realignment was performed using the Genome Analysis Tool Kit
(GATK version v2.3–6) to perform and to produce a cleaned BAM file [49]. The genome data
has been made freely available under accession no. PRJEB7903 at the European Nucleotide
Archive. Variant calls were then made with the unified genotyper module of GATK. Variant
data for each sample were obtained in variant call format (version 4.0) as raw calls for all sam-
ples and sites flagged using the variant filtration module of GATK. Variant calls that failed to
pass the following filters were labelled accordingly in the call set: (i) Hard to Validate MQ04
& ((MQ0/(1.0  DP))>0.1); (ii) strand bias (low Quality scores) QUAL<30.0 || (Quality by
depth) QD<5.0 || (homopolymer runs) HRun>5 || (strand bias) SB>0.00; (iii) SNP cluster
window size 10. The snpEFF software [50] together with the CanFam 3.1 annotation was used
to predict the functional effects of detected variants. The following snpEFF categories of vari-
ants were considered as non-synonymous: NON_SYNONYMOUS_CODING, CODON_DE-
LETION, CODON_INSERTION, CODON_CHANGE_PLUS_CODON_DELETION,
CODON_CHANGE_PLUS_CODON_INSERTION, FRAME_SHIFT, EXON_DELETED,
START_GAINED, START_LOST, STOP_GAINED, STOP_LOST, SPLICE_SITE_ACCEP-
TOR, SPLICE_SITE_DONOR.
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Mutation analysis of canine TECPR2
Primers for the amplification of the TECPR2 variant (forward GACAGACGGACACCC
TGTTC, reverse CAGATCCACCACCCTCAATC) were designed using Primer3 software
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi) after masking repetitive
sequences with RepeatMasker (http://www.repeatmasker.org). For sequencing, a 490 bp PCR
product was amplified using AmpliTaqGold360 DNA polymerase (LifeTechnologies, Darm-
stadt, Germany). The subsequent re-sequencing of the PCR products was performed after
rAPid alkaline phosphatase (Roche, Basel, Switzerland) and exonuclease I (New England Bio-
labs, Frankfurt, Germany) treatment with the ABI BigDye Terminator Sequencing Kit 3.1
(LifeTechnologies) on an ABI 3730 genetic analyzer. Sequence data were analyzed with
Sequencher 4.9 (GeneCodes, Ann Arbor, USA).
Protein sequence analysis
Multiple sequence alignment was performed with ClustalW (http://www.ebi.ac.uk/Tools/msa/
clustalw2/). GeneBank accession numbers used for DNA, RNA alignments were: i) for
TECPR2: NC_006590, XM_005623828.1; XP_005623885.1 (canis lupus familiaris). Further
accession numbers used for the TECPR2 and TECPR1 protein alignments are listed in S2
Table. The Peroxin-23 sequence is available from UniProtKB/Swiss-Prot: Q9VWB0.2 (Dro-
sophila melanogaster). Impact of the mutations on the protein stability and structure was pre-
dicted with the following software tools: PolyPhen2 [51], NetTurnP [52], NetSurfP [53], the
Chou&Fasman secondary structure prediction server CFSSP [54], PoPMuSiC [55], and Phyre2
[56].
Supporting Information
S1 Fig. Iron staining of the basal ganglia/ Globus pallidus of a NAD affected Spanish water
dog. Using Turnbull’s blue (A) and Prussian blue staining (B), no iron deposition was detected
in the basal ganglia. Positive control stain (granulation tissue with numerous haemosidero-
phages) for Turnbull’s blue (C) and Prussian blue (D). Bar: 20 μm.
(TIF)
S2 Fig. Linkage analysis of NAD in Spanish water dogs. Graphical LOD score statistics for
NAD are shown per dog chromosome.
(PDF)
S3 Fig. Alignment of TECPR2 (sixth propeller domain) and TECPR1 (ninth propeller
domain) in vertebrate and non-vertebrate species. The arginine residue that is substituted by
a tryptophan (p.R1337W) in NAD affected Spanish water dogs is highly conserved in the
TECPR1 orthologs. The homology of the sixth and ninth propeller domain of TECPR2 and
TECPR1 further indicates the functional relevance of this C-terminal propeller domain.
(PDF)
S4 Fig. TECPR2 immunohistochemistry of the spinal cord using an human TECPR2 spe-
cific antibody, the avidin-biotin-peroxidase complex method, the chromogen 3,30-dia-
mino-benzidine tetrahydrochloride, and Mayer's hematoxylin as counterstain. TECPR2
expression was detected in neurons in the grey matter of affected dogs (A) and age-matched
control Beagle dogs (B). Bar: 20 μm.
(TIF)
S1 Table. Classification of inherited or idiopathic neuroaxonal dystrophies in humans.
(PDF)
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S2 Table. GeneBank accession numbers used for the TECPR2 and TECPR1 alignments.
(PDF)
S1 Video. Clinical presentation of a NAD affected Spanish water dog aged 23 months.
(MP4)
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